The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntertek Group Regulatory News (ITRK)

Share Price Information for Intertek Group (ITRK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,948.00
Bid: 4,946.00
Ask: 4,950.00
Change: 0.00 (0.00%)
Spread: 4.00 (0.081%)
Open: 4,982.00
High: 4,988.00
Low: 4,884.00
Prev. Close: 4,948.00
ITRK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition

4 Mar 2024 07:00

RNS Number : 3669F
Intertek Group PLC
04 March 2024
 

INTERTEK STRENGTHENS GLOBAL MINERALS OFFERING WITH ACQUISITION OF LEADING PROVIDER OF METALLURGICAL TESTING SERVICES

 

4 March 2024

 

· The demand for minerals testing continues to grow, underpinned by strong fundamentals, with significant growth potential in Minerals that are important for advanced technology and the energy transition

 

· The acquisition of Base Met Labs will expand Intertek's industry leading ATIC offering in the Minerals industry, growing its geographic footprint into North America

 

· Base Met Labs' leading metallurgy capabilities is highly complementary to Intertek's existing strengths in geochemistry, mine site laboratories and trade inspection, creating attractive synergies across the Intertek ATIC Minerals project cycle

 

More information is available here: https://www.intertek.com/investors/basemetlabs-video/

 

Intertek Group plc ("Intertek" and "Group"), a Total Quality Assurance provider to a range of industries worldwide, announces that it has agreed to acquire Base Metallurgical Laboratories Ltd. and Base Met Labs US Ltd. ("Base Met Labs"), a leading provider of metallurgical testing services for the Minerals sector based in North America.

 

In order to meet the demands of a growing global population, a variety of energy sources and minerals will be needed, heightening the requirement for mission-critical, end-to-end Total Quality Assurance solutions across the resource development chain.

 

Founded in 2014 and operating from laboratories in Kamloops, British Columbia and Tucson, Arizona, Base Met Labs' specialist focus on metallurgy capabilities complements Intertek's existing strengths in geochemistry, mine site laboratories and trade inspection, creating attractive commercial synergies within Intertek's high-quality service portfolio. The acquisition broadens the Group's differentiated ATIC offering in the Minerals industry, expanding its Americas footprint to access the largest and growing market for mining activity globally, across Canada, the United States and Central and South America.

 

With a testing focus on gold, copper and other critical metals, Base Met Labs benefits from growing demand for minerals testing underpinned by strong fundamentals, with significant growth potential in battery and energy metals that will help the world's leading mining companies accelerate into a sustainable future.

 

The acquisition will capitalise on the recent success of the Group's innovative Minerals Global Centre of Excellence in Perth Australia, one of the world's largest and most advanced minerals laboratories, strengthening our position in the industry.

 

Base Met Labs employs over 40 people and generated revenues of £7.8m in 2023.

 

André Lacroix, Chief Executive Officer of Intertek, said: "There is no doubt that, with a growing population and the rise in demand for raw materials, the requirement for leading ATIC solutions at every stage of the minerals and mining supply chain globally is increasing rapidly. The acquisition of Base Met Labs is highly complementary to our ATIC service offering, establishes a Minerals testing footprint for Intertek on the American continent and creates attractive growth opportunities with existing and new clients. We welcome the Base Met Labs team to Intertek and look forward to working together to help the world's leading mining companies accelerate into a sustainable future, enabling us to fulfil our mission of making the world a better, safer, more sustainable place for all."

 

 

For further information please contact:

 

Denis Moreau, Investor Relations

Telephone: +44 (0) 20 7396 3415 investor@intertek.com

 

Jonathon Brill/James Styles, Dentons Global Advisors

Telephone: +44 (0)7836 622 683 intertek@dentonsglobaladvisors.com

 

 

 

About Intertek

 

Intertek is a leading Total Quality Assurance provider to industries worldwide.

 

Our network of more than 1,000 laboratories and offices in more than 100 countries, delivers innovative and bespoke Assurance, Testing, Inspection and Certification solutions for our customers' operations and supply chains. Intertek is a purpose-led company that brings Quality, Safety and Sustainability to Life.

 

Our Science-based Customer Excellence USP and the 24/7 mission critical Quality Assurance solutions we provide, ensure that our clients can operate with well-functioning supply chains in each of their operations.

 

Our Customer Promise is: Intertek Total Quality Assurance expertise, delivered consistently, with precision, pace and passion, enabling our customers to power ahead safely.

 

intertek.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQEANDDEDLLEFA
Date   Source Headline
22nd Mar 20249:00 amRNSAnnual Financial Report
14th Mar 20241:00 pmRNSDirector/PDMR Shareholding
14th Mar 20241:00 pmRNSDirector/PDMR Shareholding
13th Mar 20241:00 pmRNSDirector/PDMR Shareholding
5th Mar 20247:00 amRNSFinal Results
4th Mar 20247:00 amRNSAcquisition
1st Mar 20241:00 pmRNSDirectorate Change
28th Feb 20241:00 pmRNSDirector/PDMR Shareholding
23rd Nov 20237:00 amRNSTrading Statement
22nd Nov 20231:00 pmRNSBlock listing Interim Review
14th Sep 20231:00 pmRNSDirector Declaration
24th Aug 20237:00 amRNSAcquisition
28th Jul 20237:00 amRNSHalf-year Report
12th Jul 202310:00 amRNSDirectorate Change
7th Jun 20231:00 pmRNSDirector/PDMR Shareholding
31st May 20231:00 pmRNSDirector/PDMR Shareholding
30th May 20233:00 pmRNSHolding(s) in Company
30th May 20231:00 pmRNSBlock listing Interim Review
24th May 202311:00 amRNSResult of AGM
24th May 20237:00 amRNSTrading Statement
3rd May 20237:00 amRNSCapital Markets Event
27th Apr 20234:00 pmRNSDirector Declaration
26th Apr 20234:30 pmRNSDirector Declaration
20th Apr 20234:00 pmRNSDirector Declaration
3rd Apr 20237:00 amRNSAcquisition
24th Mar 20239:00 amRNSNotice of 2023 AGM
21st Mar 20239:00 amRNSAnnual Financial Report
20th Mar 20237:00 amRNSDirectorate Change
14th Mar 20233:00 pmRNSDirector/PDMR Shareholding
14th Mar 20233:00 pmRNSDirector/PDMR Shareholding
14th Mar 20233:00 pmRNSDirector/PDMR Shareholding
28th Feb 20237:00 amRNSFinal Results
23rd Dec 202210:00 amRNSDirectorate Change
13th Dec 202211:00 amRNSDirector Declaration
12th Dec 20221:00 pmRNSDirector Declaration
24th Nov 20227:00 amRNSTrading Statement
21st Nov 20221:00 pmRNSBlock listing Interim Review
2nd Aug 20229:00 amRNSDirector/PDMR Shareholding
29th Jul 20227:01 amRNSAcquisition
29th Jul 20227:00 amRNSHalf-year Report
21st Jun 20221:00 pmRNSDirector/PDMR Shareholding
26th May 20227:00 amRNSDirectorate Change
25th May 202211:00 amRNSResult of AGM
25th May 20227:00 amRNSTrading Statement
23rd May 20221:00 pmRNSBlock listing Interim Review
4th Apr 20223:00 pmRNSDirector/PDMR Shareholding
22nd Mar 20221:00 pmRNSDirector/PDMR Shareholding
22nd Mar 20221:00 pmRNSDirector/PDMR Shareholding
18th Mar 20229:00 amRNSAnnual Financial Report
14th Mar 20221:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.